| [1] |
Guo H，Callaway JB，Ting JP.Inflammasomes: mechanism of action, role in disease, and therapeutics[J]．Nat Med，2015，21(7)：677-687.
|
| [2] |
Park SH，Shin EC.Direct ex vivo functional analysis of HCV-specific t cells[J]．Methods Mol Biol，2019，1911：349-361.
|
| [3] |
Estevez J，Chen VL，Podlaha O，et al.Differential serum cytokine profiles in patients with chronic hepatitis b，c，and hepatocellular carcinoma[J]．Sci Rep，2017，7(1)：11867.
|
| [4] |
Yang R，Gao N，Chang Q，et al.The role of IDO，IL-10, and TGF-beta in the HCV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma[J]．J Med Virol，2019，91(2)：265-271.
|
| [5] |
中华医学会肝病学分会，中华医学会感染病学分会．丙型肝炎防治指南(2015更新版)[J]．中华临床感染病杂志，2015，8(6)：504-525.
|
| [6] |
Pang X，Wang Z，Zhai N，et al.IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid：polycytodylic acid[J]．Int Immunopharmacol，2016，38：284-290.
|
| [7] |
Niesen E，Schmidt J，Flecken T，et al.Suppressive effect of interleukin 10 on priming of naive hepatitis C virus-specific CD8＋ T cells[J]．J Infect Dis，2015，211(5)：821-826.
|
| [8] |
Liu BS，Groothuismink ZM，Janssen HL，et al.Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections[J]．J Leukoc Biol，2011，89(6)：981-988.
|
| [9] |
Couper KN，Blount DG，Riley EM.IL-10: the master regulator of immunity to infection[J]．J Immunol，2008，180(9)：5771-5777.
|
| [10] |
Flynn JK，Dore GJ，Hellard M，et al.Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users[J]．J Viral Hepat，2011，18(8)：549-561.
|
| [11] |
Antoniades CG，Wendon J，Vergani D．Paralysed monocytes in acute on chronic liver disease[J]．J Hepatol，2005，42(2)：163-165.
|
| [12] |
Fabregat I，Caballero-Díaz D．Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis[J]．Frontiers in Oncology，2018，8：357.
|
| [13] |
Verma V，Chakravarti A，Kar P．Cytokine levels of TGF-beta, IL-10, and sTNFalphaRII in type C chronic liver disease[J]．Dig Dis Sci，2008，53(8)：2233-2237.
|
| [14] |
Fabregat I，Moreno-Caceres J，Sanchez A，et al.TGF-beta signalling and liver disease[J]．FEBS J，2016，283(12)：2219-2232.
|
| [15] |
Sheng J，Chen W，Zhu HJ.The immune suppressive function of transforming growth factor-beta(TGF-beta)in human diseases[J]．Growth Factors，2015，33(2)：92-101.
|
| [16] |
Martinez-Esparza M，Tristan-Manzano M，Ruiz-Alcaraz AJ，et al.Inflammatory status in human hepatic cirrhosis[J]．World J Gastroenterol，2015，21(41)：11522-11541.
|
| [17] |
Segura-Cerda CA，Aceves-Sanchez MJ，Perez-Koldenkova V，et al.Macrophage infection with combinations of BCG mutants reduces induction of TNF-alpha, IL-6, IL-1beta and increases IL-4[J]．Tuberculosis (Edinb)，2019，115：42-48.
|
| [18] |
Waqas S，Ampem G，Roszer T．Analysis of IL-4/STAT6 Signaling in Macrophages[J]．Methods Mol Biol，2019，1966：211-224.
|
| [19] |
Zhao J，Jiang L，Deng L，et al.Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4 Ralpha therapeutic antibody[J]．MAbs，2019：11(5)：837-847.
|
| [20] |
Impellizzieri D，Ridder F，Raeber ME，et al.IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation[J]．J Allergy Clin Immunol，2019，144(1)：267-279.
|
| [21] |
Boccardi V，Westman E，Pelini L，et al.Differential associations of IL-4 with hippocampal subfields in mild cognitive impairment and alzheimer's disease[J]．Front Aging Neurosci，2019，10：439.
|
| [22] |
Carneros D，Santamaria EM，Larequi E，et al.Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization[J]．FASEB J，2019，33(6)：7578-7587.
|
| [23] |
Hao G，Duan W，Sun J，et al.Effects of febuxostat on serum cytokines IL-1，IL-4，IL-6, IL-8, TNF-alpha and COX-2[J]．Exp Ther Med，2019，17(1)：812-816.
|
| [24] |
Ha JW，You MJ，Park HS，et al.Differential effect of LPS and paclitaxel on microglial functional phenotypes and circulating cytokines: the possible role of CX3CR1 and IL-4/10 in blocking persistent inflammation[J]．Arch Pharm Res，2019，42(4)：359-368.
|